BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 35064256)

  • 1. Hippo signalling in the liver: role in development, regeneration and disease.
    Russell JO; Camargo FD
    Nat Rev Gastroenterol Hepatol; 2022 May; 19(5):297-312. PubMed ID: 35064256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis.
    Nishina H
    Cancer Sci; 2022 Jun; 113(6):1900-1908. PubMed ID: 35349740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.
    Zhu J; Wu T; Lin Q
    Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine.
    Moya IM; Halder G
    Nat Rev Mol Cell Biol; 2019 Apr; 20(4):211-226. PubMed ID: 30546055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment.
    Johnson R; Halder G
    Nat Rev Drug Discov; 2014 Jan; 13(1):63-79. PubMed ID: 24336504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. YAPping about and not forgetting TAZ.
    Callus BA; Finch-Edmondson ML; Fletcher S; Wilton SD
    FEBS Lett; 2019 Feb; 593(3):253-276. PubMed ID: 30570758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Hippo signaling pathway in liver regeneration and tumorigenesis.
    Hong L; Cai Y; Jiang M; Zhou D; Chen L
    Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):46-52. PubMed ID: 25476204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Hippo pathway and its correlation with acute kidney injury.
    Zhang C; Li CL; Xu KX; Zheng ZH; Cheng GZ; Wu HJ; Liu J
    Zool Res; 2022 Sep; 43(5):897-910. PubMed ID: 36052554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).
    Gandhirajan RK; Jain M; Walla B; Johnsen M; Bartram MP; Huynh Anh M; Rinschen MM; Benzing T; Schermer B
    J Biol Chem; 2016 May; 291(22):11596-607. PubMed ID: 27048650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hippo pathway - brief overview of its relevance in cancer.
    Zygulska AL; Krzemieniecki K; Pierzchalski P
    J Physiol Pharmacol; 2017 Jun; 68(3):311-335. PubMed ID: 28820389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Hippo signaling pathway: from multiple signals to the hallmarks of cancers.
    Zhu N; Yang R; Wang X; Yuan L; Li X; Wei F; Zhang L
    Acta Biochim Biophys Sin (Shanghai); 2023 Mar; 55(6):904-913. PubMed ID: 36942989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway.
    Jang JW; Kim MK; Bae SC
    Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of the mammalian Hippo signaling pathway.
    Ji XY; Zhong G; Zhao B
    Yi Chuan; 2017 Jul; 39(7):546-567. PubMed ID: 28757470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
    Juan WC; Hong W
    Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic Hippo signaling inhibits development of hepatocellular carcinoma.
    Liu Y; Wang X; Yang Y
    Clin Mol Hepatol; 2020 Oct; 26(4):742-750. PubMed ID: 32981290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roles of Hippo-YAP/TAZ signalling in intervertebral disc degeneration.
    Zheng-Wei S; Yuan T; Chao-Shuai F; Lei Z; Zong-Rang S; Tuan-Jiang L; Ding-Jun H
    Biomed Pharmacother; 2023 Mar; 159():114099. PubMed ID: 36641923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of Hippo-YAP/TAZ signaling pathway in mechanotransduction.].
    Ishihara E; Nishina H
    Clin Calcium; 2016; 26(12):1751-1756. PubMed ID: 27885187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YAP/TAZ for cancer therapy: opportunities and challenges (review).
    Guo L; Teng L
    Int J Oncol; 2015 Apr; 46(4):1444-52. PubMed ID: 25652178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex roles of Hippo-YAP/TAZ signaling in hepatocellular carcinoma.
    Shi H; Zou Y; Zhong W; Li Z; Wang X; Yin Y; Li D; Liu Y; Li M
    J Cancer Res Clin Oncol; 2023 Nov; 149(16):15311-15322. PubMed ID: 37608027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Hippo Pathway: Biology and Pathophysiology.
    Ma S; Meng Z; Chen R; Guan KL
    Annu Rev Biochem; 2019 Jun; 88():577-604. PubMed ID: 30566373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.